Bartlett Susan J, Krishnan Jerry A, Riekert Kristin A, Butz Arlene M, Malveaux Floyd J, Rand Cynthia S
Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Pediatrics. 2004 Feb;113(2):229-37. doi: 10.1542/peds.113.2.229.
Little is known about how depressive symptoms in mothers affects illness management in inner-city children with asthma.
Our goal was to determine how maternal depressive symptoms influence child medication adherence, impact of the child's asthma on the mother, and maternal attitudes and beliefs.
Baseline and 6-month surveys were administered to 177 mothers of young minority children with asthma in inner-city Baltimore, MD and Washington, DC. Medication adherence, disruptiveness of asthma, and select attitudes toward illness and asthma therapy were measured. Six-month data (N = 158) were used to prospectively evaluate long-term symptom control and emergency department use. Independent variables included asthma morbidity, age, depressive symptoms, and other psychosocial data.
No difference in child asthma morbidity was observed between mothers high and low in depressive symptoms. However, mothers with high depressive symptoms reported significantly more problems with their child using inhalers properly (odds ratio [OR]: 5.0; 95% confidence interval [CI]: 1.3-18.9) and forgetting doses (OR: 4.2; 95% CI: 1.4-12.4). Depressive symptoms were also associated with greater emotional distress and interference with daily activities caused by the child's asthma, along with less confidence in asthma medications, ability to control asthma symptoms, and self-efficacy to cope with acute asthma episodes. In addition, depressed mothers reported less understanding about their child's medications and use (OR: 7.7; 95% CI: 1.7-35.9). Baseline asthma morbidity, maternal depression scores, and family income were independently associated with asthma symptoms 6 months later, whereas medication adherence was not predictive of subsequent asthma morbidity or emergency department use.
Maternal depressive symptoms were not associated with child asthma morbidity but were associated with a constellation of beliefs and attitudes that may significantly influence adherence to asthma medications and illness management. Identifying and addressing poor psychological adjustment in mothers is important when developing a child's asthma treatment and may facilitate parent-provider communication, medication adherence, and asthma management among inner-city children.
关于母亲的抑郁症状如何影响市中心区哮喘患儿的疾病管理,目前所知甚少。
我们的目标是确定母亲的抑郁症状如何影响儿童药物依从性、儿童哮喘对母亲的影响以及母亲的态度和信念。
对马里兰州巴尔的摩市和华盛顿特区市中心区177名患有哮喘的少数族裔幼儿的母亲进行了基线调查和为期6个月的随访调查。测量了药物依从性、哮喘的干扰性以及对疾病和哮喘治疗的特定态度。利用6个月的数据(N = 158)前瞻性评估长期症状控制和急诊科就诊情况。自变量包括哮喘发病率、年龄、抑郁症状和其他社会心理数据。
抑郁症状程度高和低的母亲在儿童哮喘发病率方面未观察到差异。然而,抑郁症状严重的母亲报告称,孩子在正确使用吸入器(优势比[OR]:5.0;95%置信区间[CI]:1.3 - 18.9)和忘记服药剂量(OR:4.2;95% CI:1.4 - 12.4)方面存在更多问题。抑郁症状还与更大的情绪困扰、孩子哮喘对日常活动的干扰相关,同时对哮喘药物的信心、控制哮喘症状的能力以及应对急性哮喘发作的自我效能感较低。此外,抑郁的母亲对孩子的药物及使用的了解较少(OR:7.7;95% CI:1.7 - 35.9)。基线哮喘发病率、母亲抑郁评分和家庭收入与6个月后的哮喘症状独立相关,而药物依从性并不能预测随后的哮喘发病率或急诊科就诊情况。
母亲的抑郁症状与儿童哮喘发病率无关,但与一系列信念和态度相关,这些信念和态度可能会显著影响哮喘药物的依从性和疾病管理。在制定儿童哮喘治疗方案时,识别并解决母亲不良的心理调适问题很重要,这可能有助于城市中心区儿童的家长与医疗服务提供者之间的沟通、药物依从性及哮喘管理。